SGLT1 variants lower postprandial glucose and may protect from long-term cardiometabolic risk Oct. 26, 2018
SCHAD role in the regulation of insulin secretion in pathogenic genetic variants and mouse models Oct. 26, 2018
Takeda Pharmaceutical and Scohia Pharma identify free fatty acid FFA1 receptor agonists Oct. 23, 2018
Nrf2 pathway, novel therapeutic target for the treatment of cognitive impairment in type 1 diabetes Oct. 19, 2018
RSS